RxDoctor Payments Data

Brett Lenart, MD

Orthopaedic Surgery · New York, NYNPI 1891951661

Payments from drug & device makers

$11,625in general payments, 2019–2025

Across 26 payments — averaging $447.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$6K
  • Integra Lifesciences Corporation$3K
  • Encore Medical, LP$2K
  • Polaris Technology Solutions LLC$510
  • Gotham Surgical Solutions & Devices, Inc.$156
  • Stryker$148
  • plus $136 from 2 others

What the payments were for

  • Consulting fees$9,74384%
  • Travel & lodging$1,0769%
  • Food & beverage$8077%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew10$5,900
Integra Lifesciences Corporation2$3,125
Encore Medical, LP2$1,650
Polaris Technology Solutions LLC2$510
Gotham Surgical Solutions & Devices, Inc.2$156
Stryker6$148
Medartis Inc.1$112
Arthrex1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,625 in reported general payments places this provider in the 65th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$541,539
Medicare patients
740
Services billed
32,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium239$3,392
Celecoxib62$903
Methylprednisolone89$540
Meloxicam72$228
Naproxen39$213
Ibuprofen25$133

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →